医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

OMRON’s Fiscal 2017 Net Income Jumps 37.3%, to Record JPY63.2 Billion

2018年04月26日 PM06:22
このエントリーをはてなブックマークに追加


 

KYOTO, Japan

OMRON Corporation (TOKYO:6645) today announced its consolidated operating results for fiscal 2017, ended March 31, 2018.

Companywide growth in the core Industrial Automation and Healthcare businesses resulted in net sales rising 8.3% from a year earlier, to JPY860.0 billion. Gross profit increased 14.7%, to JPY357.7 billion, operating income advanced 27.1%, to JPY85.9 billion, and net income attributable to shareholders jumped 37.3%, to JPY63.2 billion, a record for the Company. Gross profit was also a record, with the gross profit margin gaining 2.3 percentage points, to 41.6%.
Details are available at: https://www.omron.com/about/ir/

Driven by growing worldwide demand for more labor-saving automation and high technology automation solutions in the manufacturing sector, sales at OMRON’s mainstay Industrial Automation Business rose 23%. Demand was brisk across all the company’s key focus sectors—automobile, digital devices, food processing and social infrastructure. Growth was particularly strong in such digital device areas as smartphones and semiconductors.

For fiscal 2018, the company expects net sales to rise 4.7%, to JPY900.0 billion, gross profit to increase 6.9%, to JPY382.5 billion, operating income to rise 8.3%, to JPY93.0 billion, and net income attributable to shareholders to advance 2.1%, to JPY64.5 billion. All these figures would be new highs. The Industrial Automation Business should again drive gains on the strength of automation demand in the digital devices and automobile sectors. The company also stands to benefit from progress in the Healthcare Business, reflecting a rising number of hypertension patients worldwide and greater opportunities from expansion in the healthcare data market. Management plans to lift dividends per share for the year by JPY16.0, to a record JPY92.0.
Yoshihito Yamada, President and CEO, commented that, “In fiscal 2017, we got off to a solid start with VG 2.01, our new medium-term management plan. We are well placed to reach the goals of that initiative. We will invest extensively in fiscal 2018 to accelerate earnings growth in fiscal 2018 and ensure that we continue to expand toward and beyond 2020.”

 

Financial Highlights

(Billions of yen)

    Fiscal 2016   Fiscal 2017   Change
Net sales 794.2 860.0 8.3%

Gross profit
(Gross profit margin)

311.8
(39.3%)

357.7
(41.6%)

14.7%
(2.3 percentage points)

Operating income
(Operating income margin)

67.6
(8.5%)

85.9
(10.0%)

27.1%
(1.5 percentage point)

Net income attributable to
shareholders

46.0 63.2 37.3%
Yen to U.S. dollar rate 108.9 111.2 2.3
Yen to euro rate 119.4 129.4 10.0
 

Fiscal 2018 Forecasts

    Fiscal 2017  

Fiscal 2018
forecasts

  Change
Net sales 860.0 900.0 4.7%

Gross profit
(Gross profit margin)

357.7
(41.6%)

382.5
(42.5%)

6.9%
(0.9 percentage point)

Operating income
(Operating income margin)

85.9
(10.0%)

93.0
(10.3%)

8.3%
(0.3 percentage point)

Net income attributable to
shareholders

63.2 64.5 2.1%
Yen to U.S. dollar rate 111.2 107.0 -4.2
Yen to euro rate 129.4 131.0 1.6
 

1 Details of VG 2.0 are available at: https://www.omron.com/vg2020/

About OMRON Corporation
OMRON Corporation is a global leader in the field of automation based on its core technology of “Sensing & Control + Think.” OMRON’s business fields cover a broad spectrum, ranging from industrial automation and electronic components to automotive electronic components, social infrastructure systems, healthcare, and environmental solutions. Established in 1933, OMRON has about 36,000 employees worldwide, working to provide products and services in 117 countries and regions. In the field of industrial automation, OMRON supports manufacturing innovation by providing advanced automation technologies and products, as well as through extensive customer support, in order to help create a better society. For more information, visit OMRON’s website: http://www.omron.com/

View source version on businesswire.com: https://www.businesswire.com/news/home/20180426005684/en/

CONTACT

Contact (media):
OMRON Corporation
Kisho Iida,
+81-75-344-7175
Brand Communications Department

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • SanBio: Joint Research Agreement for SB623 Targeting Dementia
  • Amway in Association With Kony Hosted First-Ever Hackathon to Advance Digital Transformation in the Industry
  • 22ndセンチュリーはFDAのニコチン低減計画が直ちに実行可能であると発表
  • Emmaus Life Sciences宣布《新英格兰医学杂志》发表 Endari™(左旋谷氨酰胺口服粉剂)治疗镰状细胞病3期试验结果
  • Alpine Immune Sciences Completes Sale of S-Nitrosoglutathione Reductase (GSNOR) Assets to Laurel Venture Capital